Tirzepatide is a widely studied peptide in current research — a dual agonist that interacts with both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor pathways simultaneously. This dual receptor activity has made Tirzepatide a subject of ongoing research interest in studies focused on peptide signaling, receptor interaction, and broader pathway dynamics. COA with every batch.
Vial Size
A triple receptor agonist studied in controlled laboratory settings across GLP-1, GIP, and glucagon receptor signaling pathways. Retatrutide is evaluated for its interaction with multi-incretin receptors, peptide signaling activity, and pathway dynamics. Supplied as a lyophilized powder, manufactured under controlled conditions, and quality tested prior to release. Certificate of analysis documentation included with every batch.
Vial Size
All compounds are manufactured for research and analytical purposes only. Not intended for human consumption, diagnostic use, or therapeutic application. Professional verification required for purchase.
Discount Applied Successfully!
Your savings have been added to the cart.
